Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 1.00 |
| ▸ | FAAH | O00519 | 2/20 | 0.84 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.84 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.55 |
| ▸ | ADH1B | P00325 | 1/20 | 0.55 |
| ▸ | ADH1C | P00326 | 1/20 | 0.55 |
| ▸ | ADH1A | P07327 | 1/20 | 0.55 |
| ▸ | ADH4 | P08319 | 1/20 | 0.55 |
| ▸ | ADH7 | P40394 | 1/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | EP300 | Q09472 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tridecanal SCHEMBL38928 | 1.00 | TSHR (1.00) | TSHRFAAHTRPV1ALDH1A1EPHX1 | |
| SCHEMBL4879845 | 1.00 | TSHR (1.00) | TSHRFAAHTRPV1ALDH1A1EPHX1 | |
| SCHEMBL9234870 | 1.00 | TSHR (1.00) | TSHRFAAHTRPV1ALDH1A1EPHX1 | |
| Decanal SCHEMBL2540 | 1.00 | TSHR (1.00) | TSHRFAAHTRPV1ALDH1A1EPHX1 | |
| Undecanal SCHEMBL22333 | 1.00 | TSHR (1.00) | TSHRFAAHTRPV1ALDH1A1EPHX1 | |
| Undecanal SCHEMBL2684955 | 1.00 | TSHR (1.00) | TSHRFAAHTRPV1ALDH1A1EPHX1 | |
| SCHEMBL120789 | 1.00 | TSHR (1.00) | TSHRFAAHTRPV1ALDH1A1EPHX1 | |
| Decanal SCHEMBL7728978 | 1.00 | TSHR (1.00) | TSHRFAAHTRPV1ALDH1A1EPHX1 | |
| Heptanal SCHEMBL10533943 | 1.00 | TSHR (1.00) | TSHRFAAHTRPV1ALDH1A1EPHX1 | |
| Tetradecanal SCHEMBL18604 | 1.00 | TSHR (1.00) | TSHRFAAHTRPV1ALDH1A1EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3664900-A1 | PHOTOSENSITIVE MICROCAPSULES | Procter & Gamble International Operations SA (CH) | 2020-06-17 | — | — | EP | disclosed |
| EP-3596192-A1 | BENEFIT AGENT CONTAINING DELIVERY PARTICLE SLURRIES | The Procter and Gamble Company (US) | 2020-01-22 | — | — | EP | disclosed |
| EP-3596195-A1 | BENEFIT AGENT CONTAINING DELIVERY PARTICLE | The Procter and Gamble Company (US) | 2020-01-22 | — | — | EP | disclosed |
| WO-2019030393-A1 | PHOTOSENSITIVE MICROCAPSULES | PROCTER & GAMBLE INTERNATIONAL OPERATIONS SA (CH) | 2019-02-14 | — | — | WO | disclosed |
| WO-2018169532-A1 | BENEFIT AGENT CONTAINING DELIVERY PARTICLE | THE PROCTER & GAMBLE COMPANY (US) | 2018-09-20 | — | — | WO | disclosed |
| WO-2018169531-A1 | BENEFIT AGENT CONTAINING DELIVERY PARTICLE SLURRIES | THE PROCTER & GAMBLE COMPANY (US) | 2018-09-20 | — | — | WO | disclosed |
| EP-3367999-A1 | FRAGRANCE COMPOSITIONS COMPRISING IONIC LIQUIDS | The Procter and Gamble Company (US) | 2018-09-05 | — | — | EP | disclosed |
| CN-108210682-A | A kind of promoting blood circulation medicine puree and preparation method for treating Osteoarthritis | 黄建民 | 2018-06-29 | — | — | CN | disclosed |
| EP-3307393-A1 | FRAGRANCE COMPOSITION | The Procter and Gamble Company (US) | 2018-04-18 | — | — | EP | disclosed |
| EP-3307394-A1 | FRAGRANCE FIXATIVES AND COMPOSITIONS COMPRISING THEREOF | The Procter and Gamble Company (US) | 2018-04-18 | — | — | EP | disclosed |
| WO-2013022949-A1 | ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2013-02-14 | — | — | WO | disclosed |
| EP-2513280-A1 | COMPOSITION COMPRISING ENCAPSULATES, AND PROCESS FOR MAKING THEM | The Procter & Gamble Company (US) | 2012-10-24 | — | — | EP | disclosed |
| EP-2512406-A1 | PERFUMES AND PERFUME ENCAPSULATES | The Procter & Gamble Company (US) | 2012-10-24 | — | — | EP | disclosed |
| EP-2496681-A1 | HIGH EFFICIENCY CAPSULES COMPRISING BENEFIT AGENT | The Procter & Gamble Company (US) | 2012-09-12 | — | — | EP | disclosed |
| WO-2012085864-A1 | ENCAPSULATES | PROCTER & GAMBLE INTERNATIONAL OPERATIONS SA (CH) | 2012-06-28 | — | — | WO | disclosed |
| WO-2011075556-A1 | COMPOSITION COMPRISING ENCAPSULATES, AND PROCESS FOR MAKING THEM | THE PROCTER & GAMBLE COMPANY (US) | 2011-06-23 | — | — | WO | disclosed |
| WO-2011075551-A1 | PERFUMES AND PERFUME ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2011-06-23 | — | — | WO | disclosed |
| WO-2011056934-A1 | HIGH EFFICIENCY CAPSULES COMPRISING BENEFIT AGENT | THE PROCTER & GAMBLE COMPANY (US) | 2011-05-12 | — | — | WO | disclosed |
| WO-2001044145-A1 | METHOD FOR THE MANUFACTURE OF OLEFINS | FORTUM OIL AND GAS OY (FI) | 2001-06-21 | — | — | WO | disclosed |
| US-5756854-A | PHOSPHINE AND THODIUM CARBONYL CATALYSTS | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-05-26 | — | — | US | disclosed |